Friday, August 01, 2014 7:34:03 AM
My Guess
I know some one who spent the whole time as ASCO with them.
They spent the majority of time talking to big Pharmacy companies and not institutions, which is a shame. Again , awareness PR .who knows.
Anyway take what you will out of that , we are on radars i believe just not the ones we want them to be on as impatient share holders.
LP is a strange one.
Look how many shares she has.
Her desire is to beat this thing, i think more than make billions of dollars.(i think her father died of cancer which is where the passion is , but don’t quote me)
Can she do one without the other........NO
i think they got squeezed a bit time wise, for results at ASCO and maybe released too early.
(This is not a criticism they can do what ever they see fit)
I am talking in hindsight, no one saw the AF stunt, which was well timed to say the least from the little toad)
BUT
As i mention , the phase 1 trail is now fully loaded .
My best guess is she will maybe wait till all have had 4 injections.
That should be around 14/15th August. Few days to get all the data together , have a think and announce.
NOW... CATCH 22
The market expects almost perfection, which is crazy right, these people are sent home to die they are so ill.
BUT
if they come out and say every patient has had a reaction like last time, the critics will be out with wanting more details.
The longer injected patients should give a clearer picture.
All in all its bloody exciting if we didn’t have so much to lose.
Now where the price will go after an announcement like that i am not sure.
BUT
THE SHEEP MAY WELL ARRIVE IN FLOCKS.
I haven’t mentioned DCVAXL as its blinded.
I think as was mentioned there are huge issues with people rushed into emergency surgery without time to educate themselves about possible treatments.
(bad work by the medical procession)
Should have NWBO offered to take a sample of all GBM patients at certain hospitals then approach them, again who knows they only have so many staff.
Germans , at the cost of repeating myself …
How cruel beauracracy when you offer a treatment on a disease with average survival of 14 months and take 6 month to price it.
MAN , THERE IS SOMETHING SERIOUSLY WRONG WITH THIS FDA . PEI, WHAT EVER THEY ARE CALLED.
They need to employ people and change the rules to get stuff done.
I know some one who spent the whole time as ASCO with them.
They spent the majority of time talking to big Pharmacy companies and not institutions, which is a shame. Again , awareness PR .who knows.
Anyway take what you will out of that , we are on radars i believe just not the ones we want them to be on as impatient share holders.
LP is a strange one.
Look how many shares she has.
Her desire is to beat this thing, i think more than make billions of dollars.(i think her father died of cancer which is where the passion is , but don’t quote me)
Can she do one without the other........NO
i think they got squeezed a bit time wise, for results at ASCO and maybe released too early.
(This is not a criticism they can do what ever they see fit)
I am talking in hindsight, no one saw the AF stunt, which was well timed to say the least from the little toad)
BUT
As i mention , the phase 1 trail is now fully loaded .
My best guess is she will maybe wait till all have had 4 injections.
That should be around 14/15th August. Few days to get all the data together , have a think and announce.
NOW... CATCH 22
The market expects almost perfection, which is crazy right, these people are sent home to die they are so ill.
BUT
if they come out and say every patient has had a reaction like last time, the critics will be out with wanting more details.
The longer injected patients should give a clearer picture.
All in all its bloody exciting if we didn’t have so much to lose.
Now where the price will go after an announcement like that i am not sure.
BUT
THE SHEEP MAY WELL ARRIVE IN FLOCKS.
I haven’t mentioned DCVAXL as its blinded.
I think as was mentioned there are huge issues with people rushed into emergency surgery without time to educate themselves about possible treatments.
(bad work by the medical procession)
Should have NWBO offered to take a sample of all GBM patients at certain hospitals then approach them, again who knows they only have so many staff.
Germans , at the cost of repeating myself …
How cruel beauracracy when you offer a treatment on a disease with average survival of 14 months and take 6 month to price it.
MAN , THERE IS SOMETHING SERIOUSLY WRONG WITH THIS FDA . PEI, WHAT EVER THEY ARE CALLED.
They need to employ people and change the rules to get stuff done.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
